FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/029731 [Registered on: 11/12/2020] Trial Registered Prospectively
Last Modified On: 09/12/2020
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of saptachakra ghanavati in the treatment of pain during menstruation. 
Scientific Title of Study   A randomized open labelled control clinical trial to evaluate the efficacy of saptachakra ghanavati in the management of Spasmodic dysmenorrhea  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vasanthi Thondambatti 
Designation  Assistant Professor 
Affiliation  Parul Institute of Ayurved and Research 
Address  Department of Prasooti tantra and streeroga Parul Institute of Ayurved and Research Ishwarapura PO: limda Waghodia, Vadodara
house no: 32/A Akshar Yug society Opposite Gayitri mandir Waghodia road Vadodra
Vadodara
GUJARAT
391760
India 
Phone  9490887152  
Fax  0  
Email  dr.vasanthi.bams@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vasanthi Thondambatti 
Designation  Assistant Professor 
Affiliation  Parul Institute of Ayurved and Research 
Address  Department of Prasooti tantra and streeroga Parul Institute of Ayurved and Research Ishwarapura PO: limda Waghodia, Vadodara
house no: 32/A Akshar Yug society Opposite Gayitri mandir Waghodia road Vadodra
Vadodara
GUJARAT
391760
India 
Phone  9490887152  
Fax  0  
Email  dr.vasanthi.bams@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vasanthi Thondambatti 
Designation  Assistant Professor 
Affiliation  Parul Institute of Ayurved and Research 
Address  Department of Prasooti tantra and streeroga Parul Institute of Ayurved and Research Ishwarapura PO: limda Waghodia, Vadodara
house no: 32/A Akshar Yug society Opposite Gayitri mandir Waghodia road Vadodra
Vadodara
GUJARAT
391760
India 
Phone  9490887152  
Fax  0  
Email  dr.vasanthi.bams@gmail.com  
 
Source of Monetary or Material Support  
Center of research for development 
 
Primary Sponsor  
Name  Center of Research for Development 
Address  Parul University Limda Waghodia, Vadodara 
Type of Sponsor  Other [Research Cell of private University] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vasanthi Thondambatti  khemdas ayurved Hospital  Department of Prasooti tantra nad streeroga OPD NO: 05 Parul institute of Ayurved and Research Ishwarapura Limda Waghodia
Vadodara
GUJARAT 
9490887152
0
dr.vasanthi.bams@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PIARIECHR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N944||Primary dysmenorrhea,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Rajapravartini Vati  250mg Three time a day after food with water 
Intervention  Saptachakra ghana vati  500mg two times a day after food with luke warm water 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  25.00 Year(s)
Gender  Female 
Details  1. Unmarried women, with regular cycle who complaint of painful menstruation,
2. without pelvic pathology
 
 
ExclusionCriteria 
Details  1. PID, endometriosis and debilitating pathological conditions of the pelvic organs ,
Women Suffering from systemic diseases, with organic lesion (benign or malignant growth of reproductive tract), any degree of prolapsed and Hypoplastic uterus,
2.Polycystic ovarian disease (pcod), any congenital abnormality of genital organs
3.Married women and irregular cycles
4.The age beyond the 25years.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief from pain
facilitation of normal menstrual flow 
The patients are fallowed in the interval of 7days 
 
Secondary Outcome  
Outcome  TimePoints 
regulerising meneses without complications.  outcomes regularly monitored every 1 month for the period of 3 months 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   21/12/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Publication is not yet completed 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Dysmenorrhea means painful menstruation which can be correlated with udavartini yonivyapad of charaka or Udavarta of sushruta. It occurs in 50% of post-pubescent females.Spasmodic dysmenorrhea is an important clinical as well as social problem affecting more than 50% of menstruating women. Though the modern medicine has made an unbelievable progress in understanding “dysmenorrhea”, no new progress has been made in the line of management. Moreover, the principal drugs i.e. NSAID’S used have many side effects in sensitive individuals, which restrict their use.Therefore, a complete, comprehensive and holistic approach toward its understanding and treatment is the need of the age. An attempt has been made here to treat this condition with drug mentioned in classics 
Close